Latest Headlines

CHAI: $48M/Year in Revenue After Funding Round by AMD and CoreWeave
PR Newswire

PR Newswire

CHAI: $48M/Year in Revenue After Funding Round by AMD and CoreWeave

7 小时前

MLTX INVESTOR DEADLINE: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
PR Newswire

PR Newswire

MLTX INVESTOR DEADLINE: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

8 小时前

UNIVERSAL MUSIC GROUP'S FAMILY OF ARTISTS, LABELS AND SONGWRITERS NOMINATED ACROSS ALL GENRES FOR THE 68TH ANNUAL GRAMMY AWARDS
PR Newswire

PR Newswire

UNIVERSAL MUSIC GROUP'S FAMILY OF ARTISTS, LABELS AND SONGWRITERS NOMINATED ACROSS ALL GENRES FOR THE 68TH ANNUAL GRAMMY AWARDS

8 小时前

Author Edith Webster Releases Six Historical Fiction Novels Exploring Love, Survival, and Redemption
PR Newswire

PR Newswire

Author Edith Webster Releases Six Historical Fiction Novels Exploring Love, Survival, and Redemption

9 小时前

The Future of Longevity and Wellness Investment to Be Highlighted at This Year's Global Wellness Summit in Dubai
PR Newswire

PR Newswire

The Future of Longevity and Wellness Investment to Be Highlighted at This Year's Global Wellness Summit in Dubai

9 小时前

Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer
PR Newswire

PR Newswire

Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer

10 小时前

inne Debuts at CIIE with Global Launch of Two New Products
PR Newswire

PR Newswire

inne Debuts at CIIE with Global Launch of Two New Products

10 小时前

Edward Smolyansky Issues Statement Regarding Lifeway Foods (NASDAQ: LWAY) Extension of Existing Rights Plan, Board Refreshment and Delayed 2025 Annual Meeting
PR Newswire

PR Newswire

Edward Smolyansky Issues Statement Regarding Lifeway Foods (NASDAQ: LWAY) Extension of Existing Rights Plan, Board Refreshment and Delayed 2025 Annual Meeting

10 小时前

SINA Investors Have Opportunity to Lead Sina Corporation Securities Fraud Lawsuit
PR Newswire

PR Newswire

SINA Investors Have Opportunity to Lead Sina Corporation Securities Fraud Lawsuit

11 小时前

U.S. FDA approves KYGEVVI™ (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)
PR Newswire

PR Newswire

U.S. FDA approves KYGEVVI™ (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)

12 小时前